Microsoft vs Revolution Medicines Inc. Common Stock — how do they compare? Microsoft trades at $528.89 (market cap $3.88T), while Revolution Medicines Inc. Common Stock trades at $189.1 (market cap $40.32B). The key difference: Microsoft is far larger — about 96.2× Revolution Medicines Inc. Common Stock's market cap, and Microsoft pays a 0.75% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Microsoft for 142 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| MSFT | RVMD | |
|---|---|---|
Market Cap | $3.88T | $40.32B |
Volume | 19,593,392 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $542.07 | $221.15 |
52-Week Low | $352.83 | $47.50 |
Typical Hold Time | 142 Days | 0 Days |
Enterprise Value | $3.86T | $37.02B |
Dividend Yield | 0.75% | — |
Signals from Pluang's Aura AI — not financial advice
Microsoft trades at $529.76, up 0.09% with strong bullish technical signals and consistent earnings beats. The company maintains robust fundamentals with $281.72B revenue, 40.31% net margin, and positive cash flow. Recent analyst coverage shows 82% buy ratings with a $571.76 consensus target, while technical indicators suggest support at $526 and resistance at $533.
Outlook remains positive with AI leadership driving growth, though elevated P/E of 29.11 and competitive pressures present risks. The stock offers solid dividend income and institutional support, but investors should monitor capital expenditure trends and market rotation away from mega-cap tech stocks.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →